Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

PARICALCITOL Drug Profile

« Back to Dashboard

What is the patent landscape for Paricalcitol, and what generic alternatives are available?

Paricalcitol is a drug marketed by Sandoz Canada Inc, Eci Pharms Llc, Dr Reddys Labs Ltd, Hikma Pharms, Rising Pharms Inc, Amneal Pharms, Teva Pharms Usa, Bionpharma Inc, Marksans Pharma, Hospira Inc, Aurobindo Pharma Ltd, Accord Hlthcare, and Amneal Pharms Co. and is included in fourteen NDAs.

The generic ingredient in PARICALCITOL is paricalcitol. There are ten drug master file entries for this compound. Nineteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the paricalcitol profile page.

Summary for Tradename: PARICALCITOL

Patents:0
Applicants:13
NDAs:14
Suppliers / Packagers: see list16
Bulk Api Vendors: see list39
Clinical Trials: see list24
Patent Applications: see list701
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PARICALCITOL at DailyMed

Pharmacology for Tradename: PARICALCITOL

Ingredient-typeCholecalciferol
Drug ClassVitamin D3 Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co
PARICALCITOL
paricalcitol
SOLUTION;INTRAVENOUS206699-002Mar 9, 2017APRXNoNo► Subscribe► Subscribe
Hospira Inc
PARICALCITOL
paricalcitol
SOLUTION;INTRAVENOUS201657-002Oct 21, 2014APRXNoNo► Subscribe► Subscribe
Marksans Pharma
PARICALCITOL
paricalcitol
CAPSULE;ORAL204948-001Oct 7, 2016ABRXNoNo► Subscribe► Subscribe
Hospira Inc
PARICALCITOL
paricalcitol
SOLUTION;INTRAVENOUS201657-003Oct 21, 2014APRXNoNo► Subscribe► Subscribe
Marksans Pharma
PARICALCITOL
paricalcitol
CAPSULE;ORAL204948-002Oct 7, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot